Global Cell Cryopreservation Market is Growing Due to Increasing Infertility and Rising Requirement for Cell Therapies.

The global cell cryopreservation market is growing due to the increasing requirement for personalized therapies, regenerative medicine, and biobanking services and rising reliance on fertility preservation services.

According to the Markets and Data Research report, “Global Cell Cryopreservation Market Assessment, Opportunities and Forecast, 2018-2032F”, global cell cryopreservation market was estimated at USD 11.19 billion in 2024 and is anticipated to reach USD 50.88 billion by 2032, growing at a CAGR of 21.0% during the forecast period. The market’s demand is rapidly growing owing to the significant advancements in cellular therapy research, along with the increasing utilization of cell therapies for treating a wide range of diseases and disorders. Cell cryopreservation plays an essential role in protecting the viability of the cells during the freezing and thawing procedures, which are extremely important for cell therapy applications. Moreover, cryopreservation also plays a vital role in the production and transportation of vaccines. The growing burden of various chronic diseases and rising reliance on vaccines to combat them is thus providing lucrative growth opportunities for the market.

Additionally, the rapid expansion of the aging population in different regions due to increased life expectancy and declining birth rates, particularly in developed regions such as North America and Europe and East Asia, is also impacting the adoption rate of cryopreservation. This demographic shift is driving the demand for regenerative medicine, personalized therapies, and biobanking services that rely on cryopreserved cells. Societal trends of delaying parenthood for career, financial stability, or personal reasons are further increasing demand for fertility preservation services, including egg and sperm cryopreservation. Additionally, public understanding and acceptance of stem cell therapies is increasing, supported by educational campaigns, media coverage, and positive clinical outcomes.

Spread through 367 pages, the "Global Cell Cryopreservation Market" report includes an in-depth TOC, many market data figures, latest market developments, key drivers and opportunities, and a thorough study of major company profiles. Moreover, the report offers strategic recommendations, pricing analysis, market share analysis, and value chain analysis in detail.

Click Here To Get Full Analysis Report: https://www.marketsandata.com/industry-reports/cell-cryopreservation-market

Key Takeaways:

• The growth of the cell cryopreservation market is driven by technological advancements, including integration of automation and artificial intelligence in protocols for improving its quality and precision. Furthermore, rapid advancements in freezing techniques and cryoprotectants are improving cell viability post-thaw.
• Cryogenic vials account for a significant share of the global cell cryopreservation market due to their essential role in safely storing biological samples at extremely low temperatures. These vials are crucial for maintaining the integrity and viability of cells, tissues, and biomaterials, which are vital for research, clinical applications, and biobanking. The increasing reliance on biobanks and the growing demand for personalized medicine and genomic research is also driving the need for robust storage solutions. Cryogenic vials offer exceptional sealing performance, ease of sample collection, and mobility, making them indispensable in various fields, including medical research, diagnostics, and industrial applications. Their ability to preserve samples without degradation over time ensures high-quality results in research studies and clinical applications.
• The market’s expansion is further propelled by increasing requirement for cryopreservation in regenerative medicine, drug discovery, and fertility treatments. This rising requirement can be attributed to the role of the technology in ensuring the viability of cells for longer periods of time for research and therapeutic purposes.
• Although North America accounts for the major share of the market, the market in Asia-Pacific is going to witness rapid growth over the forecast period due to declining birth rate in different countries across the region, increasing emphasis on research and development activities, and destigmatization of fertility preservation services.

Global cell cryopreservation market is segmented in the following categories:

By Product: Consumables, Cell Freezing Media, Equipment

By Application: Stem Cells, Oocytes and Embryotic Cells, Sperm Cells, Hepatocytes, Others

By End-user: Biopharmaceutical and Pharmaceutical Companies, Research Institutes, Biobanks, IVF Clinics, Others

By Region: North America, Europe, South America, Asia-Pacific, Middle East and Africa

Based on product, consumables account for the major share of the global cell cryopreservation market due to their crucial role in minimizing contamination and transportation of cryopreserved material. Additionally, the growing emphasis on cell-based therapies due to the increasing burden of autoimmune disease, neurological disorders, and cancer, among others is also bolstering the demand for consumable. The high demand for these consumables is also driven by the rising infertility rates and the growing need for long-term storage of biological samples.

Based on application, stem cells account for the major share of the global cell cryopreservation market due to their critical role in regenerative medicine and research. Cryopreservation allows for the long-term storage of stem cells without compromising their viability, making them readily available for various applications, including treating chronic diseases, tissue repair, and drug discovery. Additionally, the rising efforts of different governments to promote stem cells, organs, and blood donations among different ethnicities are also boosting the segment’s expansion.

Based on end-user, IVF clinics account for the majority of the global market for cell cryopreservation due to rising requirements for fertility preservation services because of increasing incidences of infertility. As per the estimates of the WHO, 1 in 6 adults across the globe experience infertility during their lifetime. Thus, propelling the requirement cryopreservation solutions to ensure the viability of frozen sperm and eggs for long periods of time. The growing acceptance of assisted reproductive technologies (ARTs) in various regions across the globe is another major factor propelling the requirement for reliance on IVF clinics. Meanwhile, various government and non-government organizations (NGOs) are also working on raising awareness about infertility, destigmatizing ARTs, and promoting education and understanding.

North America accounts for the major share of the global cell cryopreservation market due to the presence of advanced healthcare infrastructure, high investments in research and development activities in life science and biomedical industries and increasing acceptance of fertility preservation technologies. Moreover, the strong presence of leading market players in the region also provides lucrative growth opportunities for the market by ensuring the availability of advanced and novel technologies. Meanwhile, the Asia-Pacific is going to witness rapid growth over the forecast period due to rising cases of infertility and low birth rates in different countries. Various governments are focusing on introducing programs and schemes to support the population in their fertility preservation efforts. As of January 2024, more than 7,000 women in Japan have registered for information sessions for Tokyo’s fertility subsidy program, that offers up to USD 2,023 (300,000 yen) for egg freezing.

Download Free Sample Report

Major Companies Operating in Global Cell Cryopreservation Market Include:

• Merck & Co., Inc.
• Thermo Fisher Scientific Inc.
• Lonza Group Ltd. 
• GE HealthCare Technologies Inc. 
• BioLife Solutions Inc.
• Sartorius AG
• STEMCELL Technologies Canada Inc.
• Artivion, Inc
• Takara Bio Inc.
• Corning Incorporated

The key players of the market are focusing on expanding their product portfolios and manufacturing facilities to strengthen their position in the market. Leading market players are heavily investing in research and development activities to ensure the availability of advanced freezing equipment and cryoprotectants, to improve cell viability.

In April 2024, Thermo Fisher Scientific Inc. launched TSX Universal Series of ultra-low temperature freezers, designed for enhanced performance, user experience, and energy efficiency. These freezers feature Universal V-Drive technology for tighter temperature control and faster recovery times, adapting to various lab settings. The series has achieved ISO Class 5.5 cleanroom designation, making it suitable for cell and gene therapy applications.

“Global Cell Cryopreservation Market Assessment, 2018-2032F”, evaluates the future growth potential of global cell cryopreservation market and provides statistics and information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision-makers to take investment decisions for their organizations more strategically. Moreover, the report identifies and examines the emerging trends along with key drivers, challenges, and opportunities in global cell cryopreservation market.

Contact

Mr. Vivek Gupta

5741 Cleveland street,

Suite 120, VA beach, VA, USA 23462

Tel: +1 (757) 343-3258

Email: info@marketsandata.com

Website: https://www.marketsandata.com